What side effects are associated with this type of intervention?

Educational feedback interventions for alcohol consumption, such as the Drinking Dashboard, generally have minimal physical side effects but may cause emotional discomfort as individuals confront their drinking behaviors. Pharmacological treatments like naltrexone can cause nausea, headache, dizziness, and fatigue. Behavioral therapies, including cognitive-behavioral therapy (CBT) and motivational interviewing, typically have no direct physical side effects but can lead to emotional distress as patients address challenging issues related to their alcohol use.

What prior FDA approvals exist?

FDA-approved treatments for alcohol dependence include acamprosate and naltrexone. Acamprosate helps maintain abstinence by stabilizing chemical balance in the brain, while naltrexone reduces cravings and the pleasurable effects of alcohol. These pharmacological treatments differ from the educational feedback approach studied in the Drinking Dashboard trial, which aims to reduce alcohol consumption by increasing awareness of risk factors and consequences of blackout through behavioral intervention.

What other types of research exist?

Promising novel alternatives to the Drinking Dashboard for alcohol consumption patients include: 1) Mobile health applications that offer personalized feedback and real-time monitoring, such as those using Ecological Momentary Assessment (EMA) techniques. 2) Internet-based interventions that provide structured programs and support through online platforms. 3) Social network-based interventions, like those leveraging platforms such as Facebook or Twitter, to create supportive communities and peer accountability. 4) Telehealth services that offer remote counseling and therapy sessions, making treatment more accessible. 5) Wearable devices that track physiological markers and provide feedback on alcohol consumption patterns.

← Back to Search

Behavioral Intervention

Drinking Dashboard for Reducing Blackout Drinking Risks

N/A

Recruiting

Led By Mary Beth Miller, PhD

Research Sponsored by University of Missouri-Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to follow-up (1 and 3 months)

Awards & highlights

Study Summary

This trial tests if a "Drinking Dashboard" can help people reduce the risks of blackout drinking by giving weekly feedback.

Who is the study for?

This study is for young adults aged 18-30 who binge drink weekly and have experienced any form of alcohol-induced memory loss in the past month. It's not suitable for individuals with urgent psychiatric needs like psychosis or severe suicidal thoughts.Check my eligibility

What is being tested?

The trial is testing a 'Drinking Dashboard,' which gives participants weekly feedback on their drinking habits, specifically focusing on risk factors and consequences related to blackouts from alcohol use.See study design

What are the potential side effects?

Since this intervention involves providing information rather than medication, traditional side effects are not expected. However, there may be psychological impacts from receiving personal feedback about risky behaviors.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to follow-up (1 and 3 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to follow-up (1 and 3 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to follow-up (1 and 3 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Alcohol-related consequences

Frequency of blackouts

+4 more

Secondary outcome measures

Blackout self-efficacy

Blackout severity

Blackout susceptibility

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Drinking DashboardExperimental Treatment1 Intervention

Day-level feedback on alcohol use and consequences

Group II: Assessment OnlyActive Control1 Intervention

Daily assessment control group

Do I qualify?Apply below to find out

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Educational feedback interventions, such as those studied in the Drinking Dashboard trial, work by providing personalized feedback on drinking patterns, risk factors, and consequences of alcohol use. This approach increases awareness and motivates behavior change by highlighting the risks associated with excessive drinking. For patients, this means gaining critical knowledge and self-awareness, which are essential for reducing alcohol consumption and maintaining healthier drinking behaviors.

Effectiveness of brief alcohol interventions in primary care populations.Ultra-brief intervention for problem drinkers: results from a randomized controlled trial.Brief interventions for heavy alcohol users admitted to general hospital wards.

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor

367 Previous Clinical Trials

628,255 Total Patients Enrolled

Mary Beth Miller, PhDPrincipal InvestigatorUniversity of Missouri-Columbia

2 Previous Clinical Trials

123 Total Patients Enrolled

Media Library

Drinking Dashboard (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05630625 — N/A

Alcohol Consumption Research Study Groups: Assessment Only, Drinking Dashboard

Alcohol Consumption Clinical Trial 2023: Drinking Dashboard Highlights & Side Effects. Trial Name: NCT05630625 — N/A

Drinking Dashboard (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05630625 — N/A

~62 spots leftby Feb 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.